GALECTIN THERAPEUTICS INC Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Galectin Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Galectin Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.07M, a 1.09% increase year-over-year.
  • Galectin Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$39.6M, a 1.08% decline year-over-year.
  • Galectin Therapeutics Inc annual Operating Income (Loss) for 2023 was -$38.1M, a 0.73% increase from 2022.
  • Galectin Therapeutics Inc annual Operating Income (Loss) for 2022 was -$38.4M, a 27.1% decline from 2021.
  • Galectin Therapeutics Inc annual Operating Income (Loss) for 2021 was -$30.2M, a 28.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.